| Primary |
| Attention Deficit/hyperactivity Disorder |
76.9% |
| Depression |
4.6% |
| Constipation |
3.1% |
| Disturbance In Attention |
3.1% |
| Antidepressant Therapy |
1.5% |
| Bipolar Disorder |
1.5% |
| Drug Ineffective |
1.5% |
| Fluid Retention |
1.5% |
| Narcolepsy |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Sleep Apnoea Syndrome |
1.5% |
| Smoking Cessation Therapy |
1.5% |
|
| Vision Blurred |
14.5% |
| Suicidal Ideation |
10.9% |
| Product Substitution Issue |
7.3% |
| Suicide Attempt |
7.3% |
| Weight Decreased |
7.3% |
| Migraine |
5.5% |
| Physical Assault |
5.5% |
| Vomiting |
5.5% |
| Fatigue |
3.6% |
| Intracranial Aneurysm |
3.6% |
| Macular Degeneration |
3.6% |
| Product Quality Issue |
3.6% |
| Psychomotor Hyperactivity |
3.6% |
| Therapeutic Response Unexpected With Drug Substitution |
3.6% |
| Toxic Encephalopathy |
3.6% |
| Tremor |
3.6% |
| Abdominal Pain Upper |
1.8% |
| Chest Pain |
1.8% |
| Colon Cancer |
1.8% |
| Completed Suicide |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
58.6% |
| Drug Use For Unknown Indication |
7.5% |
| Completed Suicide |
6.6% |
| Drug Abuse |
3.7% |
| Antiretroviral Therapy |
2.9% |
| Suicide Attempt |
2.9% |
| Accidental Drug Intake By Child |
2.3% |
| Foetal Exposure During Pregnancy |
2.3% |
| Schizophrenia |
2.3% |
| Attention Deficit/hyperactivity Disorder |
1.7% |
| Drug Dependence |
1.7% |
| Accidental Overdose |
1.1% |
| Ill-defined Disorder |
1.1% |
| Substance Use |
1.1% |
| Narcolepsy |
0.9% |
| Post-traumatic Stress Disorder |
0.9% |
| Anxiety |
0.6% |
| Depression |
0.6% |
| Pancreatic Neuroendocrine Tumour Metastatic |
0.6% |
| Premature Labour |
0.6% |
|
| Completed Suicide |
16.3% |
| Toxicity To Various Agents |
13.8% |
| Intentional Drug Misuse |
8.8% |
| Drug Abuse |
7.5% |
| Death |
6.3% |
| Respiratory Arrest |
6.3% |
| Unresponsive To Stimuli |
6.3% |
| Tremor |
5.0% |
| Substance Abuse |
3.8% |
| Suicidal Ideation |
3.8% |
| Drug Exposure During Pregnancy |
2.5% |
| Drug Interaction |
2.5% |
| Injury |
2.5% |
| Multi-organ Failure |
2.5% |
| Multiple Drug Overdose Intentional |
2.5% |
| Overdose |
2.5% |
| Somnolence |
2.5% |
| Weight Decreased |
2.5% |
| Acute Hepatic Failure |
1.3% |
| Alanine Aminotransferase Increased |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.8% |
| Drug Use For Unknown Indication |
13.4% |
| Depression |
11.6% |
| Bipolar Disorder |
8.0% |
| Attention Deficit/hyperactivity Disorder |
5.4% |
| Multiple Sclerosis |
5.4% |
| Pain |
5.4% |
| Anxiety |
4.5% |
| Sleep Disorder |
4.5% |
| Drug Exposure During Pregnancy |
2.7% |
| Fatigue |
2.7% |
| Hormone Replacement Therapy |
2.7% |
| Nasopharyngitis |
2.7% |
| Asthma |
1.8% |
| Bipolar I Disorder |
1.8% |
| Bladder Disorder |
1.8% |
| Headache |
1.8% |
| Hypersensitivity |
1.8% |
| Insomnia |
1.8% |
| Premedication |
1.8% |
|
| Accidental Poisoning |
10.0% |
| Overdose |
10.0% |
| Poisoning |
10.0% |
| Premature Separation Of Placenta |
10.0% |
| Hypertension |
7.5% |
| Ventricular Tachycardia |
7.5% |
| Drug Screen Positive |
5.0% |
| Mood Swings |
5.0% |
| Pneumonia |
5.0% |
| Weight Increased |
5.0% |
| Abdominal Pain Lower |
2.5% |
| Accident |
2.5% |
| Agitation |
2.5% |
| Cough |
2.5% |
| Death |
2.5% |
| Drowning |
2.5% |
| Drug Abuse |
2.5% |
| Drug Dependence |
2.5% |
| Drug Dose Omission |
2.5% |
| Drug Effect Decreased |
2.5% |
|
| Interacting |
| Product Used For Unknown Indication |
75.0% |
| Chest Pain |
8.3% |
| Hypertension |
8.3% |
| Smoking Cessation Therapy |
8.3% |
|
| Toxicity To Various Agents |
50.0% |
| Drug Interaction |
25.0% |
| Therapeutic Response Unexpected |
25.0% |
|
